79 results
PRRN14A
ANIK
Anika Therapeutics Inc.
6 Apr 23
Revised preliminary proxy statement filed by non-management
5:24pm
. Moreover, the Company eliminated its performance restricted units as part of the compensation package for NEOs after missing all its performance criteria
PREC14A
ANIK
Anika Therapeutics Inc.
30 Mar 23
Preliminary proxy with contested solicitation
5:12pm
eliminated its performance restricted units as part of the compensation package for NEOs after missing all its performance criteria in 2020; Caligan believes
8-K
cnjyo1c
5 Aug 20
Anika Appoints Michael Levitz as Chief Financial Officer
5:04pm
8-K
EX-10.1
9e56x3nis9bd2qsc tkq
5 Aug 20
Anika Appoints Michael Levitz as Chief Financial Officer
5:04pm
8-K
EX-10.1
9k7u8c5p3x5ni7t 2v8k
2 Mar 20
Departure of Directors or Certain Officers
4:05pm